Prospective Study About the Association of Radiotherapy and Cetuximab in the Treatment of Epidermoid Cancers, Locally Advanced, of the Head and Neck.

Centre Oscar Lambret7 个研究点分布在 1 个国家目标入组 57 人2006年10月6日

适应症Epidermoid Head and Neck Cancer

干预措施Cetuximab Radiotherapy

概览

阶段: 不适用
干预措施: Cetuximab
疾病 / 适应症: Epidermoid Head and Neck Cancer
发起方: Centre Oscar Lambret
入组人数: 57
试验地点: 7
主要终点: Skin toxicities
状态: 已完成
最后更新: 上个月

概览研究者入排标准研究组 & 干预措施结局指标研究点相似试验

概览

简要总结

This study evaluates the skin toxicities in patients with epidermoid cancer, treated by Radiotherapy in association with Cetuximab.

详细描述

This prospective and multicentric study evaluates the skin toxicities in patients with locally Advanced head and neck epidermoid cancer, treated by Radiotherapy in association with Cetuximab.

注册库

clinicaltrials.gov

开始日期

2006年10月6日

结束日期

2014年10月1日

最后更新

上个月

研究类型

Observational

性别

All

研究者

发起方

Centre Oscar Lambret

责任方

Sponsor

入排标准

入选标准

•Age \> 18 years
•Epidermoid head and neck carcinoma locally advanced
•Indication of Cetuximab and radiotherapy
•Karnofsky \>= 60
•Patients participating to another compatible study could be included after consultation with the study director Patients could be beforehand treated for an other ORL cancer
•The radiotherapy will be delivered for curative aim (minimal dose 66 Gy)